Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive' on
Target Price
The average target price of ALC.AX is 0.11 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell